Tapewire

OTC · USD

CTRVP

Hepion Pharmaceuticals, Inc.

Export transactions ↓
Tapewire entity
8208
SEC CIK
0001583771
Parsed reports
99

Last 12 months

Inside the activity.

12 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202650
May 202600
Jun 202600
Jul 202600
Aug 202660
Sep 202610
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 18, 2021 Filed Feb 18, 2021 21:05 UTC
Foster Robert TDirector · CEO and Director
PurchaseCommon Stock 20,000 $2.00 $40,000.00
Disclosure

SEC source: 0001104659-21-025199 · tm217063-2_4seq1.xml · nonDerivative · entry 1

Foster Robert T · CIK 0001677370 · Director · CEO and Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,259

Read SEC document
February 16, 2021 Filed Feb 18, 2021 16:06 UTC PurchaseCommon Stock 10,000 $2.20 $22,000.00
Disclosure

SEC source: 0001104659-21-025200 · tm217063-3_4seq1.xml · nonDerivative · entry 1

Wijngaard Peter · CIK 0001778501 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Read SEC document
December 18, 2020 Filed Dec 21, 2020 09:17 UTC PurchaseCommon Stock 20,000 $1.91 $38,200.00
Disclosure

SEC source: 0001104659-20-137755 · tm2038991d1_4.xml · nonDerivative · entry 1

Wijngaard Peter · CIK 0001778501 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Read SEC document
December 08, 2020 Filed Dec 8, 2020 18:56 UTC
Foster Robert TDirector · CEO and Director
PurchaseCommon Stock 25,000 $1.58 $39,417.50
Disclosure

SEC source: 0001104659-20-133141 · tm2037967-1_4seq1.xml · nonDerivative · entry 1

Foster Robert T · CIK 0001677370 · Director · CEO and Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,259

Read SEC document
December 02, 2020 Filed Dec 2, 2020 23:05 UTC PurchaseCommon Stock 7,000 $1.53 $10,710.00
Disclosure

SEC source: 0001104659-20-131656 · a4.xml · nonDerivative · entry 1

BRANCACCIO JOHN P · CIK 0001276551 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,008

Read SEC document
December 01, 2020 Filed Dec 2, 2020 00:53 UTC
JACOB GARY SDirector
PurchaseCommon Stock 12,000 $1.66 $19,920.00
Disclosure

SEC source: 0001104659-20-131213 · a4.xml · nonDerivative · entry 1

JACOB GARY S · CIK 0001266802 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,059

Read SEC document
November 25, 2020 Filed Nov 30, 2020 16:53 UTC
Cavan John TChief Financial Officer
PurchaseCommon Stock 4,500 $1.62 $7,290.00
Disclosure

SEC source: 0001104659-20-130531 · a4.xml · nonDerivative · entry 1

Cavan John T · CIK 0001503738 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,800

Read SEC document
August 19, 2020 Filed Aug 21, 2020 16:15 UTC GrantStock Options · Derivative 30,000 $0.00 Strike: $3.72 $0.00
Disclosure

SEC source: 0001104659-20-097592 · a4.xml · derivative · entry 1

Wijngaard Peter · CIK 0001778501 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Common Stock · 30,000 shares

Expires 2030-08-19

Read SEC document
August 19, 2020 Filed Aug 21, 2020 20:15 UTC
JACOB GARY SDirector
GrantStock Options · Derivative 30,000 $0.00 Strike: $3.72 $0.00
Disclosure

SEC source: 0001104659-20-097593 · a4.xml · derivative · entry 1

JACOB GARY S · CIK 0001266802 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 92,785

Underlying: Common Stock · 30,000 shares

Expires 2030-08-19

Read SEC document
August 19, 2020 Filed Aug 21, 2020 16:16 UTC GrantStock Options · Derivative 30,000 $0.00 Strike: $3.72 $0.00
Disclosure

SEC source: 0001104659-20-097598 · a4.xml · derivative · entry 1

ADAMS THOMAS PHD · CIK 0001234366 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 91,050

Underlying: Common Stock · 30,000 shares

Expires 2030-08-19

Read SEC document
August 19, 2020 Filed Aug 21, 2020 20:16 UTC GrantStock Options · Derivative 30,000 $0.00 Strike: $3.72 $0.00
Disclosure

SEC source: 0001104659-20-097596 · a4.xml · derivative · entry 1

BRANCACCIO JOHN P · CIK 0001276551 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 91,332

Underlying: Common Stock · 30,000 shares

Expires 2030-08-19

Read SEC document
August 19, 2020 Filed Aug 21, 2020 16:17 UTC
Lippa ArnoldDirector
GrantStock Options · Derivative 30,000 $0.00 Strike: $3.72 $0.00
Disclosure

SEC source: 0001104659-20-097600 · a4.xml · derivative · entry 1

Lippa Arnold · CIK 0001363763 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 91,110

Underlying: Common Stock · 30,000 shares

Expires 2030-08-19

Read SEC document
August 19, 2020 Filed Aug 21, 2020 16:15 UTC
Cavan John TChief Financial Officer
GrantStock Options · Derivative 160,000 $0.00 Strike: $3.72 $0.00
Disclosure

SEC source: 0001104659-20-097591 · a4.xml · derivative · entry 1

Cavan John T · CIK 0001503738 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 381,060

Underlying: Common Stock · 160,000 shares

Expires 2030-08-19

F1 · derivative.exercise_date: 53,333 of the stock options vest on 8/19/2021 and the remainder vests monthly in equal amounts over 24 months.

Read SEC document
August 19, 2020 Filed Aug 21, 2020 20:17 UTC
Foster Robert TDirector · CEO,CSO and Director
GrantStock Options · Derivative 212,000 $0.00 Strike: $3.72 $0.00
Disclosure

SEC source: 0001104659-20-097602 · a4.xml · derivative · entry 1

Foster Robert T · CIK 0001677370 · Director · CEO,CSO and Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 601,879

Underlying: Common Stock · 212,000 shares

Expires 2030-08-19

F1 · derivative.exercise_date: 70,667 of the stock options vest on 8/19/2021 and the remainder vests monthly in equal amounts over 24 months.

Read SEC document
August 19, 2020 Filed Aug 21, 2020 20:17 UTC GrantStock Options · Derivative 30,000 $0.00 Strike: $3.72 $0.00
Disclosure

SEC source: 0001104659-20-097599 · a4.xml · derivative · entry 1

Block Timothy M. · CIK 0001593465 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 91,276

Underlying: Common Stock · 30,000 shares

Expires 2030-08-19

Read SEC document
June 25, 2020 Filed Jun 25, 2020 19:18 UTC GrantStock Options · Derivative 30,000 $0.00 Strike: $2.73 $0.00
Disclosure

SEC source: 0001104659-20-076967 · a4.xml · derivative · entry 1

Wijngaard Peter · CIK 0001778501 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2030-06-25

F1 · derivative.exercise_date: 10,000 of the options vest on each of 6/25/2021, 2022 and 2023.

Read SEC document
April 03, 2020 Filed Apr 7, 2020 20:13 UTC
JACOB GARY SDirector
GrantStock Options · Derivative 60,000 $0.00 Strike: $1.63 $0.00
Disclosure

SEC source: 0001104659-20-044169 · a4.xml · derivative · entry 1

JACOB GARY S · CIK 0001266802 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,729

Underlying: Common Stock · 60,000 shares

Expires 2030-04-03

Read SEC document
April 03, 2020 Filed Apr 7, 2020 16:15 UTC GrantStock Option · Derivative 60,000 $0.00 Strike: $1.63 $0.00
Disclosure

SEC source: 0001104659-20-044175 · a4.xml · derivative · entry 1

ADAMS THOMAS PHD · CIK 0001234366 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,051

Underlying: Common Stock · 60,000 shares

Expires 2030-04-03

Read SEC document
April 03, 2020 Filed Apr 7, 2020 20:14 UTC GrantStock Options · Derivative 60,000 $0.00 Strike: $1.63 $0.00
Disclosure

SEC source: 0001104659-20-044171 · a4.xml · derivative · entry 1

BRANCACCIO JOHN P · CIK 0001276551 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,275

Underlying: Common Stock · 60,000 shares

Expires 2030-04-03

Read SEC document
April 03, 2020 Filed Apr 7, 2020 16:14 UTC
Lippa ArnoldDirector
GrantStock Options · Derivative 60,000 $0.00 Strike: $1.63 $0.00
Disclosure

SEC source: 0001104659-20-044173 · a4.xml · derivative · entry 1

Lippa Arnold · CIK 0001363763 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,109

Underlying: Common Stock · 60,000 shares

Expires 2030-04-03

Read SEC document
April 03, 2020 Filed Apr 7, 2020 20:13 UTC
Foster Robert TDirector · CEO and CSO
GrantStock Options · Derivative 380,000 $0.00 Strike: $1.63 $0.00
Disclosure

SEC source: 0001104659-20-044170 · a4.xml · derivative · entry 1

Foster Robert T · CIK 0001677370 · Director · CEO and CSO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 389,879

Underlying: Common Stock · 380,000 shares

Expires 2030-04-03

F1 · derivative.exercise_date: 126,667 of the stock options vest on 4/3/2021 and the remainder vests monthly in equal amounts over 24 months.

Read SEC document
April 03, 2020 Filed Apr 7, 2020 16:13 UTC
Cavan John TChief Financial Officer
GrantStock Options · Derivative 215,000 $0.00 Strike: $1.63 $0.00
Disclosure

SEC source: 0001104659-20-044168 · a4.xml · derivative · entry 1

Cavan John T · CIK 0001503738 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 221,059

Underlying: Common Stock · 215,000 shares

Expires 2030-04-03

F1 · derivative.exercise_date: 71,667 of the stock options vest on 4/3/2021 and the remainder vests monthly in equal amounts over 24 months.

Read SEC document
April 03, 2020 Filed Apr 7, 2020 20:14 UTC GrantStock Options · Derivative 60,000 $0.00 Strike: $1.63 $0.00
Disclosure

SEC source: 0001104659-20-044174 · a4.xml · derivative · entry 1

Block Timothy M. · CIK 0001593465 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,220

Underlying: Common Stock · 60,000 shares

Expires 2030-04-03

Read SEC document
July 24, 2019 Filed Jul 25, 2019 20:16 UTC
JACOB GARY SDirector
GrantStock Options · Derivative 970 $0.00 Strike: $3.24 $0.00
Disclosure

SEC source: 0001104659-19-041850 · a4.xml · derivative · entry 1

JACOB GARY S · CIK 0001266802 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,729

Underlying: Common Stock · 970 shares

Expires 2029-07-24

Read SEC document
July 24, 2019 Filed Jul 25, 2019 16:15 UTC GrantStock Options · Derivative 970 $0.00 Strike: $3.24 $0.00
Disclosure

SEC source: 0001104659-19-041845 · a4.xml · derivative · entry 1

ADAMS THOMAS PHD · CIK 0001234366 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,051

Underlying: Common Stock · 970 shares

Expires 2029-07-24

Read SEC document
July 24, 2019 Filed Jul 25, 2019 20:16 UTC GrantStock Options · Derivative 970 $0.00 Strike: $3.24 $0.00
Disclosure

SEC source: 0001104659-19-041849 · a4.xml · derivative · entry 1

BRANCACCIO JOHN P · CIK 0001276551 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,275

Underlying: Common Stock · 970 shares

Expires 2029-07-24

Read SEC document
July 24, 2019 Filed Jul 25, 2019 16:15 UTC
Lippa ArnoldDirector
GrantStock Options · Derivative 970 $0.00 Strike: $3.24 $0.00
Disclosure

SEC source: 0001104659-19-041843 · a4.xml · derivative · entry 1

Lippa Arnold · CIK 0001363763 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,109

Underlying: Common Stock · 970 shares

Expires 2029-07-24

Read SEC document
July 24, 2019 Filed Jul 25, 2019 16:16 UTC
Cavan John TChief Financial Officer
GrantStock Options · Derivative 5,820 $0.00 Strike: $3.24 $0.00
Disclosure

SEC source: 0001104659-19-041851 · a4.xml · derivative · entry 1

Cavan John T · CIK 0001503738 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,059

Underlying: Common Stock · 5,820 shares

Expires 2029-07-24

F1 · derivative.exercise_date: Options vest in three installments as follows: 1,940 options shall vest on each of July 24, 2020, 2021 and 2022.

Read SEC document
July 24, 2019 Filed Jul 25, 2019 20:15 UTC GrantStock Options · Derivative 970 $0.00 Strike: $3.24 $0.00
Disclosure

SEC source: 0001104659-19-041847 · a4.xml · derivative · entry 1

Block Timothy M. · CIK 0001593465 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,220

Underlying: Common Stock · 970 shares

Expires 2029-07-24

Read SEC document
July 24, 2019 Filed Jul 25, 2019 20:15 UTC
Foster Robert TDirector · CEO and CSO
GrantStock Options · Derivative 9,700 $0.00 Strike: $3.24 $0.00
Disclosure

SEC source: 0001104659-19-041844 · a4.xml · derivative · entry 1

Foster Robert T · CIK 0001677370 · Director · CEO and CSO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,879

Underlying: Common Stock · 9,700 shares

Expires 2029-07-24

F1 · derivative.exercise_date: Options vest in three installments as follows: 3,233 vest on each of July 24, 2020 and 2021 and 3,234 vest on July 24, 2022.

Read SEC document
July 03, 2018 Filed Jul 3, 2018 18:17 UTC
JACOB GARY SDirector
PurchaseWarrants · Derivative 8,625 $1,000.00 Strike: $1.55 $8,625,000.00
Disclosure

SEC source: 0001104659-18-043798 · a4.xml · derivative · entry 2

JACOB GARY S · CIK 0001266802 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,625

Underlying: Common Stock · 8,625 shares

Expires 2023-07-03

F3 · price: Shares of Series C Convertible Preferred Stock and Warrants were issued as part of a unit, with each unit consisting of one share of Series C Convertible Preferred Stock and 575 Warrants

Read SEC document
July 03, 2018 Filed Jul 3, 2018 18:17 UTC
JACOB GARY SDirector
PurchaseSeries C Convertible Preferred Stock · Derivative 15 $1,000.00 Strike: $1.55 $15,000.00
Disclosure

SEC source: 0001104659-18-043798 · a4.xml · derivative · entry 1

JACOB GARY S · CIK 0001266802 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15

Underlying: Common Stock · 9,678 shares

Expires not disclosed

F1 · derivative.exercise_price: Each share of Series C Convertible Preferred Stock is convertible into the number of shares of Common Stock equal to the stated value of $1,000 divided by $1.55.

F3 · price: Shares of Series C Convertible Preferred Stock and Warrants were issued as part of a unit, with each unit consisting of one share of Series C Convertible Preferred Stock and 575 Warrants

F2 · derivative.expiration_date: Shares of Series C Convertible Preferred Stock do not expire.

Read SEC document
July 03, 2018 Filed Jul 3, 2018 18:16 UTC PurchaseWarrants · Derivative 1,725 $1,000.00 Strike: $1.55 $1,725,000.00
Disclosure

SEC source: 0001104659-18-043792 · a4.xml · derivative · entry 2

BRANCACCIO JOHN P · CIK 0001276551 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,725

Underlying: Common Stock · 1,725 shares

Expires 2023-07-03

F3 · price: Shares of Series C Convertible Preferred Stock and Warrants were issued as part of a unit, with each unit consisting of one share of Series C Convertible Preferred Stock and 575 Warrants

Read SEC document
July 03, 2018 Filed Jul 3, 2018 18:16 UTC PurchaseSeries C Convertible Preferred Stock · Derivative 3 $1,000.00 Strike: $1.55 $3,000.00
Disclosure

SEC source: 0001104659-18-043792 · a4.xml · derivative · entry 1

BRANCACCIO JOHN P · CIK 0001276551 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3

Underlying: Common Stock · 1,936 shares

Expires not disclosed

F1 · derivative.exercise_price: Each share of Series C Convertible Preferred Stock is convertible into the number of shares of Common Stock equal to the stated value of $1,000 divided by $1.55.

F3 · price: Shares of Series C Convertible Preferred Stock and Warrants were issued as part of a unit, with each unit consisting of one share of Series C Convertible Preferred Stock and 575 Warrants

F2 · derivative.expiration_date: Shares of Series C Convertible Preferred Stock do not expire.

Read SEC document
July 03, 2018 Filed Jul 3, 2018 14:16 UTC
Lippa ArnoldDirector
PurchaseWarrants · Derivative 8,625 $1,000.00 Strike: $1.55 $8,625,000.00
Disclosure

SEC source: 0001104659-18-043794 · a4.xml · derivative · entry 2

Lippa Arnold · CIK 0001363763 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Linda Lippa Family Trust of 2007

Disclosed balance after: 8,625

Underlying: Common Stock · 8,625 shares

Expires 2023-07-03

F3 · price: Shares of Series C Convertible Preferred Stock and Warrants were issued as part of a unit, with each unit consisting of one share of Series C Convertible Preferred Stock and 575 Warrants

Read SEC document
July 03, 2018 Filed Jul 3, 2018 14:16 UTC
Lippa ArnoldDirector
PurchaseSeries C Convertible Preferred Stock · Derivative 15 $1,000.00 Strike: $1.55 $15,000.00
Disclosure

SEC source: 0001104659-18-043794 · a4.xml · derivative · entry 1

Lippa Arnold · CIK 0001363763 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Linda Lippa Family Trust of 2007

Disclosed balance after: 15

Underlying: Common Stock · 9,678 shares

Expires not disclosed

F1 · derivative.exercise_price: Each share of Series C Convertible Preferred Stock is convertible into the number of shares of Common Stock equal to the stated value of $1,000 divided by $1.55.

F3 · price: Shares of Series C Convertible Preferred Stock and Warrants were issued as part of a unit, with each unit consisting of one share of Series C Convertible Preferred Stock and 575 Warrants

F2 · derivative.expiration_date: Shares of Series C Convertible Preferred Stock do not expire.

Read SEC document
July 03, 2018 Filed Jul 3, 2018 14:17 UTC PurchaseWarrants · Derivative 8,625 $1,000.00 Strike: $1.55 $8,625,000.00
Disclosure

SEC source: 0001104659-18-043797 · a4.xml · derivative · entry 2

Cavan John T · CIK 0001503738 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,625

Underlying: Common Stock · 8,625 shares

Expires 2023-07-03

F3 · price: Shares of Series C Convertible Preferred Stock and Warrants were issued as part of a unit, with each unit consisting of one share of Series C Convertible Preferred Stock and 575 Warrants

Read SEC document
July 03, 2018 Filed Jul 3, 2018 14:17 UTC PurchaseSeries C Convertible Preferred Stock · Derivative 15 $1,000.00 Strike: $1.55 $15,000.00
Disclosure

SEC source: 0001104659-18-043797 · a4.xml · derivative · entry 1

Cavan John T · CIK 0001503738 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15

Underlying: Common Stock · 9,678 shares

Expires not disclosed

F1 · derivative.exercise_price: Each share of Series C Convertible Preferred Stock is convertible into the number of shares of Common Stock equal to the stated value of $1,000 divided by $1.55.

F3 · price: Shares of Series C Convertible Preferred Stock and Warrants were issued as part of a unit, with each unit consisting of one share of Series C Convertible Preferred Stock and 575 Warrants

F2 · derivative.expiration_date: Shares of Series C Convertible Preferred Stock do not expire.

Read SEC document
January 03, 2018 Filed Jan 5, 2018 13:09 UTC GrantCommon Stock 101,221 $0.00 $0.00
Disclosure

SEC source: 0001104659-18-000925 · a4.xml · nonDerivative · entry 1

Cavan John T · CIK 0001503738 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 167,947

F1 · price: The reported item represents an award of restricted stock pursuant to the Company's 2013 Equity Incentive Plan. All of the shares vested upon grant. Such shares were issued in lieu of a cash bonus to the reporting person.

Read SEC document
January 03, 2018 Filed Jan 5, 2018 13:09 UTC
SAPIRSTEIN JAMESDirector · Chief Executive Officer
GrantCommon Stock 322,092 $0.00 $0.00
Disclosure

SEC source: 0001104659-18-000924 · a4.xml · nonDerivative · entry 1

SAPIRSTEIN JAMES · CIK 0001559509 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 492,819

F1 · price: The reported item represents an award of restricted stock pursuant to the Company's 2013 Equity Incentive Plan. All of the shares vested upon grant. Such shares were issued in lieu of a cash bonus to the reporting person.

Read SEC document
January 03, 2018 Filed Jan 5, 2018 18:08 UTC
Foster Robert TChief Scientific Officer
GrantCommon Stock 100,654 $0.00 $0.00
Disclosure

SEC source: 0001104659-18-000922 · a4.xml · nonDerivative · entry 1

Foster Robert T · CIK 0001677370 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 144,736

F1 · price: The reported item represents an award of restricted stock pursuant to the Company's 2013 Equity Incentive Plan. All of the shares vested upon grant. Such shares were issued in lieu of a cash bonus to the reporting person.

Read SEC document
July 20, 2017 Filed Jul 21, 2017 16:01 UTC
Cavan John TChief Financial Officer
GrantStock Options · Derivative 15,000 $0.00 Strike: $0.58 $0.00
Disclosure

SEC source: 0001104659-17-046277 · a4.xml · derivative · entry 1

Cavan John T · CIK 0001503738 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 133,688

Underlying: Common Stock · 15,000 shares

Expires 2027-07-20

F1 · derivative.exercise_date: Options vest in three installments as follows: 5,000 vest on each of July 20, 2018, 2019 and 2020.

Read SEC document
July 06, 2017 Filed Jul 7, 2017 17:00 UTC
Sullivan-Bolyai John ZChief Medical Officer
GrantCommon Stock 58,681 $0.00 $0.00
Disclosure

SEC source: 0001104659-17-044099 · a4.xml · nonDerivative · entry 1

Sullivan-Bolyai John Z · CIK 0001668462 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,681

F1 · price: The reported item represents an award of restricted stock pursuant to the Company's 2013 Equity Incentive Plan. All of the shares vested upon grant. Such shares were issued in lieu of a cash bonus to the reporting person.

Read SEC document
July 06, 2017 Filed Jul 7, 2017 17:01 UTC GrantCommon Stock 46,726 $0.00 $0.00
Disclosure

SEC source: 0001104659-17-044101 · a4.xml · nonDerivative · entry 1

Cavan John T · CIK 0001503738 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,726

F1 · price: The reported item represents an award of restricted stock pursuant to the Company's 2013 Equity Incentive Plan. All of the shares vested upon grant. Such shares were issued in lieu of a cash bonus to the reporting person.

Read SEC document
July 06, 2017 Filed Jul 7, 2017 17:01 UTC
SAPIRSTEIN JAMESDirector · Chief Executive Officer
GrantCommon Stock 141,061 $0.00 $0.00
Disclosure

SEC source: 0001104659-17-044100 · a4.xml · nonDerivative · entry 1

SAPIRSTEIN JAMES · CIK 0001559509 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 170,727

F1 · price: The reported item represents an award of restricted stock pursuant to the Company's 2013 Equity Incentive Plan. All of the shares vested upon grant. Such shares were issued in lieu of a cash bonus to the reporting person.

Read SEC document
July 06, 2017 Filed Jul 7, 2017 21:00 UTC
Foster Robert TChief Scientific Officer
GrantCommon Stock 44,082 $0.00 $0.00
Disclosure

SEC source: 0001104659-17-044097 · a4.xml · nonDerivative · entry 1

Foster Robert T · CIK 0001677370 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,082

F1 · price: The reported item represents an award of restricted stock pursuant to the Company's 2013 Equity Incentive Plan. All of the shares vested upon grant. Such shares were issued in lieu of a cash bonus to the reporting person.

Read SEC document
June 20, 2017 Filed Jun 22, 2017 09:00 UTC PurchaseCommon Stock 20,000 $0.65 $13,000.00
Disclosure

SEC source: 0001104659-17-040822 · a4.xml · nonDerivative · entry 1

Cavan John T · CIK 0001503738 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Read SEC document
April 10, 2017 Filed Apr 11, 2017 20:02 UTC GrantStock Options · Derivative 35,000 $0.00 Strike: $1.60 $0.00
Disclosure

SEC source: 0001104659-17-022871 · a4.xml · derivative · entry 1

HOWSON TAMAR D · CIK 0001202286 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock · 35,000 shares

Expires 2027-04-10

F1 · derivative.exercise_date: Options vest in three installments as follows: 11,667 of the options vest on each of April 10, 2018 and 2019 and 11,666 vest on April 10, 2020.

Read SEC document
March 06, 2017 Filed Mar 7, 2017 16:00 UTC
SAPIRSTEIN JAMESDirector · Chief Executive Officer
GrantStock Options · Derivative 313,898 $0.00 Strike: $1.48 $0.00
Disclosure

SEC source: 0001104659-17-014835 · a4.xml · derivative · entry 2

SAPIRSTEIN JAMES · CIK 0001559509 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,761,129

Underlying: Common Stock · 313,898 shares

Expires 2027-03-06

F2 · derivative.exercise_date: Options vest in three installments as follows: 104,632 of the options vest on each of March 6, 2018 and 2019 and 104,634 vest on March 6, 2020.

Read SEC document
March 03, 2017 Filed Mar 7, 2017 16:00 UTC
SAPIRSTEIN JAMESDirector · Chief Executive Officer
GrantStock Options · Derivative 313,898 $0.00 Strike: $1.43 $0.00
Disclosure

SEC source: 0001104659-17-014835 · a4.xml · derivative · entry 1

SAPIRSTEIN JAMES · CIK 0001559509 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,447,231

Underlying: Common Stock · 313,898 shares

Expires 2027-03-03

F1 · derivative.exercise_date: Options vest in three installments as follows: 104,632 of the options vest on each of March 3, 2018 and 2019 and 104,634 vest on March 3, 2020.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.